UnitedHealth faces headwinds after a 50% stock drop and PR crises. Investors are worried about transparency and ...

Every earnings season, the headlines trumpet what analysts expect. But the filings related to insider trades that most skim ...

The DJIA is in positive territory thus far in 2025. The Dow Jones Industrial Average (DJINDICES: ^DJI) is up nearly 5% so far ...

UnitedHealth Group (NYSE:UNH), a dominant force in the U.S. health insurance market, continues to demonstrate resilience ...

UnitedHealth Group continues to slide as the broader healthcare sector shows persistent signs of weakness. Check out why I ...

Wedgewood Partners, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter ...

The best dividend stocks are not necessarily the ones with the highest dividend yields. In fact, stocks with extremely high yields often also have high payout ratios, and dividends are only as good ...

UnitedHealth stock is deeply oversold, undervalued, and primed for a recovery. Read why analysts forecast UNH to have a ~29% ...

Investors soured on the sector when Elevance, an insurer, handed in disappointing results and shared a downbeat outlook.

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $150.0 to $460.0 for UnitedHealth Group during the past quarter.

UnitedHealth Group remains a dominant force within the U.S. healthcare landscape, with a market capitalization of $272.7 billion. The company operates through its two primary arms, UnitedHealthcare ...

According to a recent SEC filing, Ayrshire Capital Management LLC fully liquidated its holding in UnitedHealth Group. The ...